Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review their AVTO6 ...
By Christy Santhosh (Reuters) -Evolus said on Thursday the U.S. drug regulator has approved its two new anti-wrinkle gels, expanding the company's product portfolio beyond its cosmetic injection ...
Emcure Pharmaceuticals on Thursday reported a 30.3% year-on-year (YoY) increase in net profit to Rs.156 crore in Q3FY25 led by strong performance of domestic and international business.
Inc. announced that the FDA has extended the PDUFA goal date for its New Drug Application (NDA) for ET-400 to May 28, 2025, allowing the agency additional time to review supplemental information ...
Drug addiction is a condition in which there is uncontrolled use of a substance with a harmful outcome. Drugs overstimulate the brain’s reward circuit, producing pleasure or euphoria. With repeated ...
Ask your doctor before you stop. They can help you come up with a schedule to help you wean yourself off the drug with minimum symptoms. Regardless of the type of antidepressant you take ...
Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...
The drug, which works by blocking pain signals before they reach the brain, is intended for short-term pain relief but is priced significantly higher than existing opioids. A tablet and bottle of ...
Trump has also promised blanket 25% tariffs on goods from Mexico and Canada by Feb. 1, citing illegal migration and drugs he claims are flowing across their borders with the U.S. Trump has said he ...
The shares of this recently listed pharma company rose nearly 2.5 percent after reporting an increase of 27 percent in net profits quarter-over-quarter.Share Price Variation In ...
says it is well placed to advance its innovative therapeutic pipeline and artificial intelligence (AI)-driven drug discovery plans. In releasing its quarterly results, the company said it is in a ...